Humacyte, Inc.
HUMA
$3.13
$0.123.99%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -152.87M | -139.66M | -105.70M | -110.78M | -89.39M |
| Total Depreciation and Amortization | 7.22M | 7.23M | 7.44M | 7.72M | 8.00M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 122.00K | 482.00K | 817.00K |
| Total Other Non-Cash Items | 49.11M | 42.15M | 14.06M | 22.70M | 6.00M |
| Change in Net Operating Assets | 5.94M | 9.58M | 2.07M | 6.57M | 1.36M |
| Cash from Operations | -90.60M | -80.70M | -82.01M | -73.31M | -73.21M |
| Capital Expenditure | -1.66M | -1.22M | -1.52M | -2.28M | -2.81M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 2.11M | 2.11M | 8.00M |
| Cash from Investing | -1.66M | -1.22M | 588.00K | -173.00K | 5.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.49M | -2.41M | -34.14M | -34.07M | -34.00M |
| Issuance of Common Stock | 44.93M | 44.54M | 43.85M | 566.00K | 619.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.40M | 19.10M | 58.01M | 38.01M | 38.01M |
| Cash from Financing | 62.84M | 61.23M | 67.71M | 4.51M | 4.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.42M | -20.69M | -13.71M | -68.97M | -63.39M |
